Get the Stockscreener App
72.07
0.73%
0.52
After Hours:
72.07
Edwards Lifesciences Corp stock is traded at $72.07, with a volume of 2.65M.
It is up +0.73% in the last 24 hours and up +3.88% over the past month.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
See More
Previous Close:
$71.55
Open:
$71.32
24h Volume:
2.65M
Relative Volume:
0.46
Market Cap:
$42.66B
Revenue:
$6.60B
Net Income/Loss:
$4.16B
P/E Ratio:
30.80
EPS:
2.34
Net Cash Flow:
$490.10M
1W Performance:
+3.64%
1M Performance:
+3.88%
6M Performance:
-18.08%
1Y Performance:
+7.31%
1-Day Range:
$71.32
$72.63
1-Week Range:
$69.16
$72.63
52-Week Range:
$58.93
$96.12
Edwards Lifesciences Corp Stock (EW) Company Profile
Name
Edwards Lifesciences Corp
Sector
Industry
Phone
(949) 250-2500
Address
ONE EDWARDS WAY, IRVINE, CA
Compare EW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-11-24 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-18-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-24 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jul-29-24 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jul-25-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-25-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-25-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-25-24 | Downgrade | TD Cowen | Buy → Hold |
| Jul-25-24 | Downgrade | Truist | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| May-14-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-07-24 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Nov-28-23 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Sep-26-23 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-08-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-06-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-31-23 | Downgrade | Bernstein | Outperform → Underperform |
| Jan-30-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-06-22 | Downgrade | Stifel | Buy → Hold |
| Oct-28-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-26-22 | Initiated | Mizuho | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-29-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-27-22 | Reiterated | Citigroup | Buy |
| Jan-27-22 | Reiterated | Evercore ISI | Outperform |
| Jan-27-22 | Reiterated | Raymond James | Outperform |
| Jan-27-22 | Reiterated | Stifel | Buy |
| Jan-27-22 | Reiterated | UBS | Neutral |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Dec-06-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-30-21 | Reiterated | Canaccord Genuity | Buy |
| Jul-30-21 | Reiterated | Deutsche Bank | Hold |
| Jul-30-21 | Reiterated | Jefferies | Buy |
| Jul-30-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-30-21 | Reiterated | Oppenheimer | Outperform |
| Jul-30-21 | Reiterated | Stifel | Buy |
| Jul-30-21 | Reiterated | UBS | Neutral |
| Jul-30-21 | Reiterated | Wells Fargo | Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Neutral |
| Apr-05-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-11-20 | Reiterated | Canaccord Genuity | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Underperform |
| Apr-28-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-17-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Neutral |
| Jan-10-20 | Initiated | Oppenheimer | Outperform |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-24-19 | Reiterated | Canaccord Genuity | Buy |
| Sep-23-19 | Initiated | Piper Jaffray | Overweight |
| Jul-24-19 | Reiterated | BofA/Merrill | Buy |
| Mar-18-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Hold |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-16-18 | Initiated | Barclays | Underweight |
| Oct-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-02-18 | Downgrade | Guggenheim | Buy → Neutral |
View All
Edwards Lifesciences Corp Stock (EW) Latest News
EW Case Alert: Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the Edwards Lifesciences Corporation Class Action - Marketscreener.com
The Manufacturers Life Insurance Company Has $124.57 Million Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Bank of Montreal Can Sells 46,215 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
EW CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Reminds InvestorsA Securities Fraud Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corporation - Markets Insider
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation - GlobeNewswire Inc.
Edwards Lifesciences Corp. stock rises Tuesday, still underperforms market - MarketWatch
Eagle Asset Management Inc. Has $2.01 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Edwards - GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure - The Bakersfield Californian
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Edwards Lifesciences shares keep Neutral rating ahead of annual investor day By Investing.com - Investing.com
Edwards Lifesciences announces positive results in one year TAVI trial - Medical Device Network
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: - GlobeNewswire
EW STOCK UPDATE: Edwards Lifesciences Investors that Lost Money when the Stock Plummeted 31% are Urged to Contact BFA Law about the Class Action Lawsuit - Newsfile
Fisher Asset Management LLC Boosts Stake in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data - BioSpace
Swedbank AB Has $63.98 Million Stake in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Shares Acquired by Algert Global LLC - MarketBeat
Edwards? SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data - Marketscreener.com
Pitcairn Co. Reduces Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Evercore ISI Group Downgrades Edwards Lifesciences (EW) - MSN
EW CLASS ACTION NOTICE: BFA Law Alerts Edwards Lifesciences Investors the Company has been Sued for Securities Fraud and Urges You to Contact the Firm - Newsfile
Edwards Lifesciences Co. (NYSE:EW) Shares Sold by Mizuho Securities USA LLC - MarketBeat
Pathstone Holdings LLC Reduces Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Corp. stock rises Friday, still underperforms market - MarketWatch
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Edwards - GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to - The Bakersfield Californian
Q1 EPS Estimate for Edwards Lifesciences Cut by Analyst - MarketBeat
Despite delivering investors losses of 39% over the past 3 years, Edwards Lifesciences (NYSE:EW) has been growing its earnings - Yahoo Finance
Integrated Investment Consultants LLC Acquires New Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Primecap Management Co. CA Lowers Stake in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Class Action Filed Against Edwards Lifesciences Corporation (EW) Seeking Recovery for InvestorsContact The Gross Law Firm - Marketscreener.com
Edwards Lifesciences Co. (NYSE:EW) Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit - Marketscreener.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation - Marketscreener.com
Are Wall Street Analysts Predicting Edwards Lifesciences Stock Will Climb or Sink? - Nasdaq
EW Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation Shareholders of Securities Fraud Class Action Lawsuit Deadline - Markets Insider
EW INVESTOR NOTICE: Edwards Lifesciences Corporation Investors w - GuruFocus.com
Brown Capital Management LLC Sells 18,661 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Are Wall Street Analysts Predicting Edwards Lifesciences Stock Will Climb Or Sink? - Barchart
Shareholders that lost money on Edwards Lifesciences Corporation(EW) Urged to Join Class ActionContact The Gross Law Firm to Learn More - Marketscreener.com
Edwards Lifesciences Co. (NYSE:EW) Position Trimmed by PNC Financial Services Group Inc. - MarketBeat
Natixis Advisors LLC Has $12.53 Million Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
EW INVESTOR NOTICE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - The Malaysian Reserve
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch
Baird Downgrades Edwards Lifesciences (EW) - MSN
EW INVESTOR NOTICE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
Howe & Rusling Inc. Grows Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Premier Fund Managers Ltd Buys Shares of 176,738 Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
80,358 Shares in Edwards Lifesciences Co. (NYSE:EW) Purchased by B. Metzler seel. Sohn & Co. Holding AG - MarketBeat
Edwards Lifesciences Corp Stock (EW) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):